Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer

Kaya, Serap; Aktas, Bilge; Sismek, Eda; Ozturk, Mehmet; DEDE, FUAT; KAYA, HANDAN; Ugurlu, MUSTAFA; Ozgen, ZERRİN; Koca, Sinan; Halil, Suleyman; Hasanov, Rahib; Alan, Ozkan; Babacan, Nalan; Ercelep, Ozlem; DANE, FAYSAL; GÜMÜŞ, MAHMUT; Yumuk, PERRAN

Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer

Atıf İçin Kopyala

Kaya S., Aktas B., Sismek E. T., Ozturk M. A., DEDE F., KAYA H., ...Daha Fazla

JOURNAL OF BUON, cilt.22, sa.5, ss.1191-1198, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 22 Sayı: 5
Basım Tarihi: 2017
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1191-1198
Anahtar Kelimeler: 18F-FDG-PET/CT, hormone-positive, locally advanced breast cancer, neoadjuvant chemotherapy, pathologic complete response, POSITRON-EMISSION-TOMOGRAPHY, SURGICAL ADJUVANT BREAST, NEOADJUVANT CHEMOTHERAPY, PREOPERATIVE CHEMOTHERAPY, EARLY PREDICTION, F-18-FDG PET/CT, SURVIVAL, THERAPY, CYCLOPHOSPHAMIDE, TRASTUZUMAB
Marmara Üniversitesi Adresli: Evet

Özet

Purpose: Current evaluation of response to neoadjuvant chemotherapy (NAC) shows that it could achieve pathological complete response (pCR). The purpose of this study was to assess the consistency of maximum uptake values (SUVmax) changes and pCR in hormone-positive locally advanced breast cancer (LABC).